Equity · Healthcare
ZYME
NASDAQZymeworks (ZYME)
The line runs 28.74 USD on 24 August through 27.51 USD on 23 September, on a scale from 24 to 32. Days the market did not trade hold the previous close, flat.
- Market cap
- 1.9B USD
- P/E (TTM)
- 52.9
- Revenue, year to Dec 2025
- 106.0M USD
- EPS, diluted, year to Dec 2025
- −1.08 USD
- 52-week range
- 15.89 USD – 31.05 USD
- Avg volume
- 41.7K
as of Sep 23, 2026
Have Zymeworks (ZYME) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, Zymeworks insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase.
Form 4, 90 days to 22 Nov 2026, newest reported trade 18 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Nov 2026 | Platshon ScottEVP, Chief Business Officer | Sell | 15,292 | 382K USD |
| 13 Nov 2026 | Moore Paul AndrewChief Scientific Officer | Sell | 39,741 | 1.0M USD |
| 09 Oct 2026 | Schayowitz AdamEVP, Head of R&D | Sell | 13,832 | 358K USD |
| Sold | 3 open-market sales | 68,865 | $1.78M |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Nov 2026 | Platshon ScottEVP, Chief Business Officer | Option exercise | 37,037 | |
| 13 Nov 2026 | Moore Paul AndrewChief Scientific Officer | Option exercise | 25,000 | 146K USD |
| 09 Oct 2026 | Schayowitz AdamEVP, Head of R&D | Option exercise | 37,037 |
Which funds hold Zymeworks (ZYME)?
10 of the 45 institutional funds we track reported a Zymeworks position for the quarter ended 30 Sep 2026 — a combined 84.0M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 1,192,391 | 31.6M USD | +30.4% |
| Fisher Asset Management | Added | 608,612 | 16.1M USD | +759.9% |
| Millennium Management | New position | 400,074 | 10.6M USD | |
| Man Group | Added | 342,191 | 9.1M USD | +62.3% |
| D. E. Shaw & Co. | Added | 233,441 | 6.2M USD | +61.2% |
| Two Sigma Investments | Added | 133,873 | 3.5M USD | +86.3% |
| AQR Capital Management | Held (±25%) | 130,337 | 3.5M USD | +17.1% |
| Point72 Asset Management | New position | 75,369 | 2.0M USD | |
| Marshall Wace | Trimmed | 27,109 | 718K USD | −33.8% |
| Renaissance Technologies | New position | 26,800 | 710K USD |
What has been filed or recorded for Zymeworks (ZYME)?
The filings we hold for Zymeworks, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 29 Oct 2026 | Fails to deliver | Shares failed to deliver | 2 shares | 58 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 2.28 USD | Revenue $256M |
| 30 Sep 2026 | Financials | Total assets | 1.2B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 258.3M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.62 USD | Revenue $5M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.59 USD | Revenue $2M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.08 USD | Revenue $106M |
| 31 Dec 2025 | Financials | Revenue | 106.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −81.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.08 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.26 USD | Revenue $28M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.03 USD | Revenue $49M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.30 USD | Revenue $27M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.62 USD | Revenue $76M |
What do people ask about Zymeworks (ZYME)?
What did Zymeworks shares close at?27.51
Zymeworks closed at 27.51 USD on 23 Sep 2026, down 0.24% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Zymeworks’ market cap?1.9B
Zymeworks is worth 1.9B USD by market value as of 23 Sep 2026, which is the share price times the shares on issue from its SEC filings.
What is Zymeworks’ P/E ratio?52.9
Zymeworks has a price-to-earnings ratio of 52.9, as of 23 Sep 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Zymeworks’ revenue?106.0M
Zymeworks reported revenue of 106.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Zymeworks insiders bought or sold shares recently?3 sales
In the 90 days to 22 Nov 2026, Zymeworks insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Zymeworks?10 of 45
10 of the 45 funds we track reported a Zymeworks position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Fisher Asset Management and Millennium Management. See Funds
When did Zymeworks last report earnings?2.28
Zymeworks last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 2.28 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words